This inventor holds 5 USPTO granted patents. Top assignees: Millennium Pharmaceuticals Limited, Millenium Pharmaceuticals, Inc.. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mahabubnager, IN (2002)
- Mahabubnagar, IN (2001 - 2003)
Company Filing History:

Years Active: 2001-2003
Title: Vavilala Goverdhan Reddy: Innovator in Cyclic Oxygen Compounds
Introduction
Vavilala Goverdhan Reddy is a notable inventor based in Mahabubnagar, India. He has made significant contributions to the field of chemistry, particularly in the development of cyclic oxygen compounds. With a total of five patents to his name, Reddy's work has implications in pharmaceutical applications and therapeutic methods.
Latest Patents
Reddy's latest patents include innovative methods for synthesizing substituted oxygen alicyclic compounds. One of his inventions provides new methods for preparing cyclic oxygen compounds, such as 2,5-disubstituted tetrahydrofurans, 2,6-disubstituted tetrahydropyrans, 2,7-disubstituted oxepanes, and 2,8-oxocanes. Additionally, he has developed methods for synthesizing the pharmaceutically active compound 2-(4-fluorophenoxymethyl)-5-(4-N-hydroxyureidyl-1-butynyl)-tetrahydrofuran and its precursors.
Career Highlights
Throughout his career, Reddy has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. His expertise in the synthesis of complex compounds has positioned him as a valuable asset in the field.
Collaborations
Reddy has collaborated with notable professionals in his field, including Mukund Shankar Chorghade and Mukund Keshao Gurjar. These collaborations have further enhanced his research and development efforts.
Conclusion
Vavilala Goverdhan Reddy's contributions to the field of cyclic oxygen compounds and his innovative methods for synthesis have made a significant impact in the pharmaceutical industry. His work continues to influence therapeutic methods and compound development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile